secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTERPACE BIOSCIENCES, INC. (IDXG)
CIK:        0001054102
Form:       8-K
Filed at:   2026-08-27T12:30:22+00:00
Accession:  0001493152-26-040329
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Interpace Biosciences announces 1-for-5 reverse stock split to support Nasdaq uplisting
--------------------------------------------------------------------------------

- 1-for-5 reverse stock split effective 12:01 a.m. ET Aug 27, 2026; shares reduced from ~27.7M to ~5.5M.
- Ticker temporarily changes to IDXGD for 20 trading days; new CUSIP 46062X402; par value unchanged at $0.01.
- Split intended to meet Nasdaq minimum bid price requirement; company also needs $15M market value of unrestricted public shares.
- Proportional adjustments to outstanding stock options, RSUs, and equity plan shares; fractional shares rounded up.
- CEO Tom Burnell: split is key part of strategy to uplist to Nasdaq and attract broader investor base.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1054102/000149315226040329/0001493152-26-040329-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1054102/000149315226040329/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-040329

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer